Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 8, Issue 2, 2006, Pages

  Sakulpipatsin, Wilaiporn ^a   Verasertniyom, Oravan ^b   Nantiruj, Kanokrat ^a   Totemchokchyakarn, Kitti ^a   Lertsrisatit, Porntawee ^a   Janwityanujit, Suchela ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL RECEPTOR;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; COHORT ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; PATHOPHYSIOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THAILAND;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; THAILAND;

EID: 39149130066     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1910     Document Type: Article

References (24)

1. Tso BP: The genetics of human Lupus 6th edition. Philadelphia: Willium & Wilkins; 2002.
2. Lemire JM: Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 1992, 49:26-31.
3. Muller K, Kriegbaum NJ, Baslund B, Sorensen OH, Thymann M, Bentzen K: Vitamin D3 metabolism in patients with rheumatic diseases: Low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 1995, 14:397-400.
4. Huckins D, Felson DT, Holick M: Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: A pilot study. Arthritis Rheum 1990, 33:1723-1727.
5. Andjelkovic Z, Vojinovic J, Pejnovic N, Popovic M, Dujic A, Mitrovic D, Pavlica L, Stefanovic D: Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients Clin Exp Rheumatol 1999, 17:453-456.
6. Eisman JA: Genetics of osteoporosis. Endocr Rev 1999, 20 788-804.
7. Carling T, Rastad J, Akerstrom G, Westin G: Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 1998, 83:2255-2259.
8. Ingles SA, Coetzee GA, Ross RK, Henderson BE, Kolonel LN, Crocitto L, Wang W, Haile RW: Association of prostate cancer with vitamin D receptor haplotypes in African-Americans. Cancer Res 1998, 58:1620-1623.
9. Ozaki Y, Nomura S, Nagahama M, Yoshimura C, Kagawa H, Fukuhara S: Vitamin-D receptor genotype and renal disorder in Japanese Japanese patients with systemic lupus erythematosus. Nephron 2000, 85 86-91.
10. Huang CM, Wu MC, Wu JY, Tsai FJ: Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 2002, 11:31-34.
11. Huang CM, Wu MC, Wu JY, Tsai FJ: No association of vitamin D receptor gene start codon fok 1 polymorphisms in Chinese patients with systemic lupus erythematosus. J Rheumatol 2002, 29:1211-1213.
12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
13. Holick MI: Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004, 79:362-371.
14. Malluche HH, Mawad H, Koszewski NJ: Update on vitamin D and its newer analogues: Actions and rationale for treatment in chronic renal failure Kidney Int 2002, 62:367-374.
15. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC: 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985, 134: 3032-3035.
16. Bhalla AK, Amento EP, Krane SM: Differential effects of 1,25- dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production Cell Immunol 1986, 98:311-322.
17. Lemire JM, Archer DC, Beck L, Spiegeburg HL: Immunosuppressive actions of 1, 25-Dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J Nutr 1995, 125:1704S-1708S.
18. Reichel H, Koeffler HP, Tobler A, Norman AW: 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA 1987, 84:3385-3389.
19. Iho S, Takahashi T, Kura F, Sugiyama H, Hoshino T: The effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J Immunol 1986, 136:4427-4431.
20. Peacock M, Turner CH, Econs MJ, Foroud T: Genetics of osteoporosis. Endocr Rev 2002, 23:303-326.
21. Voll RE, Roth EA, Girkontaite I, Fehr H, Herrmann M, Lorenz HM, Kalden JR: Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce doublestranded DNA antibody production. Arthritis Rheum 1997, 40:2162-2171.
22. Tsokos GC, Boumpas DT, Smith PL, Djeu JY, Balow JE, Rook AH: Deficient gamma-interferon production in patients with systemic lupus erythematosus. Arthritis Rheum 1986, 29:1210-1215.
23. Kelley VR, Wuthrich RP: Cytokines in the pathogenesis of systemic lupus erythematosus. Semin Nephrol 1999, 19:57-66.
24. Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Chailurkit L, Piaseu N, Teerarungsikul K, Sirisriro R, Komindr S, Puavilai G: Vitamin D receptor gene polymorphism is associated with urinary calcium excretion but not with bone mineral density in postmenopausal women. J Endocrinol Invest 1997, 20:592-596.